The Gummy Project Secures First Repeat Order from Existing Customer Bard on the Beach Life Science Investing
European Commission Approves RINVOQ® for the Treatment of Adults With Moderate to Severe Ulcerative Colitis Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sharps Compliance Corp. , Infrastructure and Energy Alternatives, Inc. , AutoWeb, Inc. , Zymergen Inc. Life Science Investing
Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 Pharmaceutical Investing
AbbVie and Allergan Aesthetics to Present New Data from Leading Neurotoxin Portfolio at TOXINS 2022 Conference Pharmaceutical Investing
Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities Life Science Investing
Kite's CAR T-cell Therapy Tecartus® Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia Pharmaceutical Investing
CHMP Adopts Positive Opinion Recommending Veklury® Receive Full Marketing Authorization for the Treatment of Patients With COVID-19 Pharmaceutical Investing
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag for Treatment of Patients with Unresectable or Metastatic Melanoma Pharmaceutical Investing
